GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stoke Therapeutics Inc (STU:0GT) » Definitions » Accumulated other comprehensive income (loss)

Stoke Therapeutics (STU:0GT) Accumulated other comprehensive income (loss) : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Stoke Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Stoke Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €0.00 Mil.

Stoke Therapeutics's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 (€-0.14 Mil) to Dec. 2023 (€-0.02 Mil) and increased from Dec. 2023 (€-0.02 Mil) to Mar. 2024 (€0.00 Mil).

Stoke Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€-0.15 Mil) to Dec. 2022 (€-1.11 Mil) but then increased from Dec. 2022 (€-1.11 Mil) to Dec. 2023 (€-0.02 Mil).

Stoke Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Stoke Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stoke Therapeutics Accumulated other comprehensive income (loss) Chart

Stoke Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial - - -0.15 -1.11 -0.02

Stoke Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.56 -0.35 -0.14 -0.02 -

Stoke Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Stoke Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Stoke Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Stoke Therapeutics (STU:0GT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stoke Therapeutics Inc (STU:0GT) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
APLT ALLK VSTM AKBA ZVRA STRO GLUE IKNA LYRA OBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
STOK:USA
Address
45 Wiggins Avenue, Bedford, MA, USA, 01730
Website
https://www.stoketherapeutics.com
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company primarily operates in the U.S.

Stoke Therapeutics (STU:0GT) Headlines

No Headlines